摘要:
A method for manufacturing a toner, including: dissolving or dispersing toner constituents including a resin, a colorant, a release agent, and a graft polymer including a polyolefin resin unit and a vinyl resin unit in a solvent, to prepare a toner constituent liquid; supplying the toner constituent liquid to a retention part configured to retain the toner constituent liquid; discharging the toner constituent liquid from the retention part to a granulation space through plural holes arranged on the retention part, while exciting the toner constituent liquid by a vibration means in contact with a part of the retention part, so that the discharged columnar toner constituent liquid is constricted to form liquid droplets; and converting the liquid droplets into solid toner particles; together with a toner manufactured by the above method.
摘要:
The present invention has its object to study synthesis of novel cyclic compounds having a pyrimidinylalkylthio group and to find pharmacological actions of the compounds. According to the present invention, a compound represented by the formula (1) or a salt thereof is provided. In the formula, the ring X represents: R1 and R2 independently represent a hydrogen atom, an alkyl group, an aryl group, an aromatic heterocyclic group or the like; R3 represents a hydrogen atom, a halogen atom, a hydroxy group, an alkoxy group, an aryloxy group, an alkyl group, an aryl group, an amino group, an alkylamino group or the like; A1 represents a sulfur atom or the like; and A2 represents an alkylene group.
摘要翻译:本发明的目的是研究具有嘧啶基烷硫基的新型环状化合物的合成,并找到化合物的药理作用。 根据本发明,提供由式(1)表示的化合物或其盐。 在该式中,环X表示:R 1和R 2分别表示氢原子,烷基,芳基,芳香族杂环基等, R 3表示氢原子,卤素原子,羟基,烷氧基,芳氧基,烷基,芳基,氨基,烷基氨基等; A1表示硫原子等; A2表示亚烷基。
摘要:
The present invention relates to Compounds represented by the formula (I) or salts thereof. In the formula (I), the ring A represents a benzene ring, a thiophene ring, or a pyridine ring; Ra represents a hydrogen atom, a halogen atom, an alkyl group, or an alkoxy group; the ring B represents a pyridine ring, a pyrimidine ring, or a quinoline ring; the ring C represents a benzene ring; a pyridine ring, a quinoline ring, or an isoquinoline ring; X and Y, the same or different, represent an oxygen atom or a sulfur atom, with the proviso that the case X is a sulfur atom and Y is an oxygen atom be excluded; R1 represents a hydrogen atom, a halogen atom, an amino group, a cycloalkylamino group, an alkylcarbonylamino group, an alkyloxycarbonylamino group, an alkylaminocarbonyl group, or a non-aromatic heterocyclic group; and R2 and R2′, the same or different, represent a hydrogen atom, a halogen atom, an alkyl group, a halogeno-alkyl group, or a halogeno-alkoxy group.
摘要:
A method for producing a toner, the method including discharging a toner composition liquid from a plurality of nozzles to form liquid droplets thereof, the toner composition liquid being prepared by dissolving or dispersing in a solvent a toner composition containing at least a binder resin, a colorant, an acid-modified hydrocarbon wax and an unmodified hydrocarbon wax, the waxes serving as a releasing agent, and solidifying the liquid droplets so as to form solid particles.
摘要:
A subject of the present invention is to provide a novel aromatic five- or six-memberd heterocyclic derivative having 4-pyridylalkylthio as a substituent or a salt thereof which is useful as a pharmaceutical. Compound represented by the following general formula [I] or salts thereof are useful as therapeutic agents for diseases in which angiogenesis or augmentation of vascular permeability is involved. In the formula, ring “A” is a benzene ring or an aromatic five- or six-memberd heterocycle which can be fused with a cycloalkane ring, “B” is alkylene, R1 and R2, the same or different, are H, OH, substituted or unsubstituted alkoxy and the like, X and Y, the same or different, are group(s) selected from H, halogen, OH, substituted or unsubstituted alkoxy and the like respectively, p is 0, 1 or 2, and q is 0 or 1.
摘要:
An image forming apparatus including an image bearing member and a developing device configured to develop an electrostatic image on the image bearing member with a toner to form a toner image thereon and including a developing unit configured to develop the electrostatic image, and a toner cartridge configured to supply the toner to the developing unit through at least one opening, wherein the developing device circulates the toner between the toner cartridge and the developing unit through the at least one opening, and wherein the internal temperature of the hopper is higher than that of the cartridge and the ratio of a charge quantity distribution parameter of the toner under a condition of 45° C. and 54% RH to that under a condition of 25° C. and 54% RH is greater than 0.9 and less than 1.5.
摘要:
An image forming apparatus includes an image bearer, a developing unit configured to develop a latent image formed on the image bearer with a toner to form a toner image, and a transfer member including a contact area that comes in contact with the image bearer. The toner image is primary transferred from the image bearer to the transfer member. A speed difference between the image bearer and the transfer member at the contact area is 0.1% or greater but 0.8% or less. The toner has an average circularity of 0.971 or greater but 0.986 or less and a shape factor SF-2 of 110 or greater but 119 or less. The speed difference is represented by the following formula: Speed difference [%]={(V1−V2)/V2}×100 [Speed difference] where V1 is a linear speed of the image bearer, and V2 is a linear speed of the transfer member.
摘要:
A method for producing a toner, including ejecting a toner composition liquid containing at least a resin and a colorant periodically from a plurality of nozzles into a chamber using a vibration unit, so as to form droplets in a gas phase; and solidifying the droplets, wherein the droplets are transported by transport air flow selected from at least one of vertical downward air flow and rotational air flow, and the method can prevent toner particles from aggregation.
摘要:
A method of treating a disease associated with angiogenesis by administering a therapeutically effective amount of a compound represented by the formula (1) or a salt thereof wherein the ring X represents R1 and R2 independently represent a hydrogen atom, an alkyl, an aryl or an aromatic heterocyclic; R3 represents a hydrogen atom, a halogen atom, a hydroxy, an alkoxy, an aryloxy, an alkyl, an aryl, an amino, an alkylamino, a cycloalkylamino, an arylamino, an alkylcarbonylamino, an arylcarbonylamino, a mercapto, an alkylthio, an arylthio, an alkylsulfinyl or a nonaromatic heterocyclic; A1 represents a sulfur atom, a sulfinyl or a sulfonyl; and A2 represents an alkylene.
摘要翻译:通过施用治疗有效量的由式(1)表示的化合物或其盐来治疗与血管生成相关的疾病的方法,其中环X表示R 1和R 2独立地表示氢原子,烷基,芳基或 芳香杂环; R 3表示氢原子,卤素原子,羟基,烷氧基,芳氧基,烷基,芳基,氨基,烷基氨基,环烷基氨基,芳基氨基,烷基羰基氨基,芳基羰基氨基,巯基,烷硫基 芳硫基,烷基亚磺酰基或非芳族杂环; A1表示硫原子,亚磺酰基或磺酰基; A2表示亚烷基。
摘要:
A toner produced by dissolving or dispersing toner components comprising a binder resin, a colorant, and a charge controlling agent in an organic solvent to prepare a toner components liquid, forming liquid droplets of the toner components liquid in a gas phase, and solidifying the liquid droplets into toner particles of the toner. The charge controlling agent includes a polycondensation reaction product of a phenol with an aldehyde.